Study Summary
This trial is testing a new drug to see if it is safe and how well it works in people with heart failure.
- Heart Failure with Reduced Ejection Fraction (HFrEF)
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 2 Secondary · Reporting Duration: Baseline through Day 90
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
LY3461767
1 of 2
Placebo
1 of 2
Experimental Treatment
Non-Treatment Group
50 Total Participants · 2 Treatment Groups
Primary Treatment: LY3461767 · Has Placebo Group · Phase 1
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 80 · All Participants · 6 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Am I eligible to join this research protocol?
"Eligibility requirements for this trial mandates that applicants are between 18-80 years of age and have a diagnosis of heart failure. Around 50 patients will be accepted into the study." - Anonymous Online Contributor
How many participants are participating in the trial?
"This trial necessitates the enrolment of 50 willing participants that satisfy established criteria. Potential subjects can sign up from Sentara Healthcare in Norfolk, Virginia and Henry Ford Hospital in Detroit, Michigan." - Anonymous Online Contributor
Are participants over 45 years old eligible for this research trial?
"Eligibility requirements for this clinical trial state that participants must be between 18 and 80 years old. Separately, there are 22 trials available to minors and 690 for seniors over 65." - Anonymous Online Contributor
Are there still opportunities for individuals to enroll in this research endeavor?
"Correct. As per the clinicaltrials.gov records, this medical study is currently recruiting patients. The trial was first initiated on June 1st 2021 and recently updated as of July 18th 2022; 50 individuals will be needed from 4 different sites for participation in the experiment." - Anonymous Online Contributor
How many locations are hosting this clinical investigation?
"This research endeavor is being conducted at four separate sites, such as Sentara Healthcare in Norfolk and the Henry Ford Hospital in Detroit. Additionally, University of North Carolina's Division of Cardiology in Chapel Hill has been included along with 4 other locations." - Anonymous Online Contributor
What type of adverse reactions have been associated with LY3461767?
"Given the limited safety data and efficacy proof, our team at Power conservatively rated LY3461767 with a score of 1." - Anonymous Online Contributor